Exhibit 4.3 FORM OF WARRANTXanodyne Pharmaceuticals Inc • November 9th, 2007 • New York
BY AND AMONGInvestor Rights Agreement • November 9th, 2007 • Xanodyne Pharmaceuticals Inc • Delaware
BACKGROUND:Master Services Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.4 Xanodyne Pharmaceuticals, Inc. Form of Incentive Stock Option Agreement Granted Under 2007 Stock Incentive Plan 1. Grant of Option. This agreement evidences the grant by Xanodyne Pharmaceuticals, Inc., a Delaware corporation (the...Xanodyne Pharmaceuticals Inc • December 18th, 2007 • Pharmaceutical preparations
BACKGROUND:Office Lease Agreement • November 9th, 2007 • Xanodyne Pharmaceuticals Inc • Kentucky
BETWEENAsset Purchase Agreement • November 9th, 2007 • Xanodyne Pharmaceuticals Inc • New York
Exhibit 10.5 Xanodyne Pharmaceuticals, Inc. Form of Nonstatutory Stock Option Agreement Granted Under 2007 Stock Incentive Plan 1. Grant of Option. This agreement evidences the grant by Xanodyne Pharmaceuticals, Inc., a Delaware corporation (the...Xanodyne Pharmaceuticals Inc • December 18th, 2007 • Pharmaceutical preparations
BY AND BETWEENManufacturing and Supply Agreement • November 9th, 2007 • Xanodyne Pharmaceuticals Inc • North Carolina
RECITALSTransfer and Assumption Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.13 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MANUFACTURING AGREEMENT This MANUFACTURING AGREEMENT (this "AGREEMENT") dated as of the first day of January,...Quality Agreement • June 10th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Ohio
EMPLOYMENT AGREEMENTEmployment Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Kentucky
The following numbered paragraphs set forth the terms and conditions that will apply if you timely sign and return this letter agreement and do not revoke it in writing within the seven (7) day period.
BACKGROUNDLicensing Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
BY AND AMONG XANODYNE PHARMACEUTICALS, INC., AS BORROWER, ANDFinancing Agreement • December 18th, 2007 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
BACKGROUNDCommercial Manufacturing Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. McKesson Corporation Core Distribution AgreementCore Distribution Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • California
This Core Distribution Agreement (“Agreement”) is entered into as of November 1 , 2005 (the “Effective Date”) between McKesson Corporation (“McKesson”), a pharmaceutical distributor, and Xanodyne Pharmaceuticals, Inc. (“Manufacturer”), a pharmaceutical company.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Master Services AgreementMaster Services Agreement • December 18th, 2007 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Kentucky
This MASTER SERVICES AGREEMENT (“Agreement”), effective February 09, 2004, by and between XANODYNE PHARMACEUTICALS INC., hereinafter referred to as “XANODYNE”, and LBR Regulatory and Clinical Consulting Services, hereinafter referred to as “CONSULTANT”, sets forth the agreement whereby CONSULTANT agrees to provide consulting services to Xanodyne and Xanodyne agrees to utilize such services from CONSULTANT according to the terms and conditions hereinafter provided.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Cardinal Health Developing Suppliers Program Distribution Services AgreementDistribution Services Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Ohio
This Agreement (“Agreement”) is entered into as of October 1, 2004 (the “Effective Date”) by and between Xanodyne Pharmaceuticals Inc. (“Supplier”), a Kentucky corporation with its principal place of business located at 7300 Turfway Rd. Suite 300, Florence, KY 41042, and Cardinal Health* (“Cardinal Health”) with its principal place of business located at 7000 Cardinal Place, Dublin, Ohio 43017.
RELOCATION SERVICES AGREEMENT between HOMESERVICES RELOCATION, LLC and XANODYNE PHARMACEUTICALS, INC.Relocation Services Agreement • December 18th, 2007 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Minnesota
This Relocation Services Agreement (this “Agreement”) is entered into by and between HomeServices Relocation, LLC, a Delaware limited liability company, with an office at 6800 France Ave. South, Suite 715, Minneapolis, MN 55435 (herein referred to as “HomeServices Relocation”) and Xanodyne Pharmaceuticals, Incorporated with its principal place of business at One Riverfront Place, Newport, KY 41071 (herein referred to as the “Company”) and is effective as of the date signed by all parties set forth below (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Kentucky
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of December 19, 2007, by and between Xanodyne Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at One Riverfront Place, Newport, Kentucky (the “Company”), and Greg Flexter, an individual (the “Employee”).
XANODYNE PHARMACEUTICALS, INC. Form of Restricted Stock Unit Agreement Granted Under 2007 Stock Incentive PlanXanodyne Pharmaceuticals Inc • January 14th, 2008 • Pharmaceutical preparations • Delaware
